In one study, a negative correlation was observed between CRABP2 and immune checkpoint molecules PD-1, PD-L1, and CTLA-4 across various types of tumors, including breast cancer, melanoma, gastric cancer, and testicular germ cell tumors. Here, CRABP2 is linked to gastric cancer.